4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene
| Names | |
|---|---|
| Preferred IUPAC name
4,4′-(4-Methylpent-1-ene-2,4-diyl)diphenol | |
| Identifiers | |
3D model (JSmol)
|
|
| Abbreviations | MBP |
| ChEBI | |
| ChemSpider | |
| ECHA InfoCard | 100.151.037 |
| EC Number |
|
| KEGG | |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C18H20O2 | |
| Molar mass | 268.356 g·mol−1 |
| Density | 1.102 g/cm3 |
| Hazards | |
| GHS labelling: | |
| Warning | |
| H315, H319, H335, H410 | |
| P261, P264, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P391, P403+P233, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) is a metabolite of bisphenol A (BPA). MBP has potent estrogenic activity in vitro and in vivo, up to thousandfold stronger than BPA. It may also play a role in neuronal cell apoptosis and may increase risk for several forms of cancer.